Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Phathom Pharmaceuticals (PHAT) over the last 6 years, with Dec 2024 value amounting to $68.4 million.

  • Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) rose 19.05% to $70.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.9 million, marking a year-over-year increase of 19.05%. This contributed to the annual value of $68.4 million for FY2024, which is 19.43% up from last year.
  • Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $68.4 million in FY2024, which was up 19.43% from $57.3 million recorded in FY2023.
  • Phathom Pharmaceuticals' 5-year Shares Outstanding (Weighted Average) high stood at $68.4 million for FY2024, and its period low was $29.0 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $57.3 million (2023), whereas its average is $55.8 million.
  • Data for Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 37.56% (in 2023) over the last 5 years.
  • Over the past 5 years, Phathom Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $29.0 million in 2020, then climbed by 8.46% to $31.4 million in 2021, then spiked by 32.49% to $41.6 million in 2022, then spiked by 37.56% to $57.3 million in 2023, then grew by 19.43% to $68.4 million in 2024.